Grove Biopharma has raised a $30 million series A round to develop Bionic Biologics, also known as protein-like polymers (PLP ...

Among the major classes of RNAs in the cell, tRNAs remain the most difficult to characterize via deep sequencing approaches, as tRNA structure and nucleotide modifications can each interfere with cDNA ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

Researchers from the International Institute of Molecular and Cell Biology in Warsaw (IIMCB) have described a new mechanism ...

The identification and intervention of Alzheimer's Disease (AD) in its early-stage allows for the timely implementation of lifestyle modifications and therapeutic strategies. Although dysregulation of ...

And notably, cells don't continue to make the frameshifted protein after the mRNA has broken down, so this is a temporary effect. Frameshifting is not uniquely associated with mRNA vaccines — it ...

The global vaccine CDMO market is set to witness a growth rate of 8% in the next 5 years. Increasing demand for vaccines, ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Moderna (MRNA – Research Report), with a price target of $32.00. The company’s shares closed yesterday ...

A deficiency in mitochondrial protein synthesis, due to the knockout of the MTO1 gene in hematopoietic cells, disrupts intracellular iron distribution, leading to fetal anemia.

Researchers identify a novel mechanism of fetal anemia linked to mitochondrial protein synthesis deficiency Date: April 9, 2025 Source: Kumamoto University Summary: A team of researchers has ...

Researchers from Agency for Science, Technology and Research in Singapore recently published a review article exploring how chromatography can be used to remove double-stranded RNA impurities during ...

Jan Vertommen, Vice President, Head of Commercial Development, Advanced Synthesis, Lonza ... The company is rapidly advancing its mRNA pipeline of immuno-modulation, protein replacement therapies, and ...